HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial-Reference-Cited by-同舟云学术

HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial

Published:1997-10 Issue:9083 Volume:350 Page:983-990
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Brun-Vezinet Francoise,Boucher Charles,Loveday Clive,Descamps Diane,Fauveau Veronique,Izopet Jacques,Jeffries Don,Kaye Steve,Krzyanowski Corinne,Nunn Andrew,Schuurman Rob,Seigneurin Jean-Marie,Tamalet Catherine,Tedder Richard,Weber Jonathan,Weverling Gerrit-Jan

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals;Lancet,1996

2. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter;Hammer;NEnglJ Med,1996

3. Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome and fewer than 200 CD4 cells per cubic millimeter;Saravolatz;N Engl J Med,1996

4. Comparative assessment of quantitative HIV viraemia assays;Rouzioux;AIDS,1992

5. Dilution assay statistics;Myers;J Clin Microbiol,1994

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and factors associated with HIV-1 drug resistance mutations in treatment-experienced patients in Nairobi, Kenya;Medicine;2021-10-08

2. Commentary on the role of treatment-related HIV compensatory mutations on increasing virulence: new discoveries twenty years since the clinical testing of protease inhibitors to block HIV-1 replication;BMC Medicine;2012-10-03

3. Standing Genetic Variation and the Evolution of Drug Resistance in HIV;PLoS Computational Biology;2012-06-07

4. Residual Activity of Two HIV Antiretroviral Regimens Prescribed without Virological Monitoring;Antimicrobial Agents and Chemotherapy;2011-07-18

5. Factors Influencing the Emergence and Spread of HIV Drug Resistance Arising from Rollout of Antiretroviral Pre-Exposure Prophylaxis (PrEP);PLoS ONE;2011-04-15